Insights On Drug Development

  1. Bridging Innovation And Clinical Reality In ADC And AOC Development 7/10/2026

    ADCs have 12+ FDA approvals; AOCs are earlier-stage but gaining momentum. Learn what CMC risks developers must address early to reach the clinic without costly detours.

  2. Lyophilization Excellence: Partnering For Sterile Fill/Finish Success 7/8/2026

    As complex therapies continue to evolve, advanced lyophilization approaches can help improve stability, consistency, scalability, and product quality.

  3. What 'One Team' Really Means In Drug Development 7/8/2026

    Replace silos with a unified drug development approach to align earlier, improve handoffs, and reduce surprises through shared visibility and proactive coordination.

  4. From Lab To Tox Batch: A First-Time-Right API Scale-Up 7/2/2026

    Gain insight into a first-time-right process that improved yield and scalability, advancing a vascular calcification inhibitor from lab scale to tox and GMP manufacturing for clinical development.

  5. Developing A Multi-Drug Combination, Antiparasitic Drug For Dogs 7/1/2026

    Looking to bring an innovative animal health product to market? See how we delivered end-to-end formulation development and rapid clinical supply manufacturing for complex multi-API products.

  6. Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles 7/1/2026

    Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.

  7. Neoantigen-Based Personalized Cancer Vaccine 7/1/2026

    Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

  8. Lipid Nanoparticles For Pulmonary Delivery Of mRNA 7/1/2026

    Gain insight into how nebulized mRNA lipid nanoparticles show preclinical success in lung delivery, offering fresh momentum for inhaled gene therapies targeting respiratory diseases.

  9. Supporting Late-Stage Drug Product Development 6/29/2026

    Meet Coriolis Pharma at CPHI Worldwide in Milan to explore solutions for late-stage drug product development, manufacturing readiness, and CMC support.

  10. Structuring ADC Analytical Partnerships From Pre-IND To Commercial 6/17/2026

    ADC success depends less on molecular design than on a continuous analytical strategy that connects early characterization to late-stage control, preventing variability, data gaps, and regulatory issues from compounding over time.